784 related articles for article (PubMed ID: 23262788)
1. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study.
Schipper RJ; Smidt ML; van Roozendaal LM; Castro CJ; de Vries B; Heuts EM; Keymeulen KB; Wildberger JE; Lobbes MB; Beets-Tan RG
Invest Radiol; 2013 Mar; 48(3):134-9. PubMed ID: 23262788
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer.
Lambregts DM; Beets GL; Maas M; Kessels AG; Bakers FC; Cappendijk VC; Engelen SM; Lahaye MJ; de Bruïne AP; Lammering G; Leiner T; Verwoerd JL; Wildberger JE; Beets-Tan RG
Ann Surg; 2011 Mar; 253(3):539-45. PubMed ID: 21239980
[TBL] [Abstract][Full Text] [Related]
3. Gadofosveset-enhanced MRI for the assessment of rectal cancer lymph nodes: predictive criteria.
Lambregts DM; Heijnen LA; Maas M; Rutten IJ; Martens MH; Backes WH; Riedl RG; Bakers FC; Cappendijk VC; Beets GL; Beets-Tan RG
Abdom Imaging; 2013 Aug; 38(4):720-7. PubMed ID: 22986353
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous bilateral breast and high-resolution axillary MRI of patients with breast cancer: preliminary results.
Luciani A; Dao TH; Lapeyre M; Schwarzinger M; Debaecque C; Lantieri L; Revelon G; Bouanane M; Kobeiter H; Rahmouni A
AJR Am J Roentgenol; 2004 Apr; 182(4):1059-67. PubMed ID: 15039188
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of gadofosveset-enhanced axillary MRI for nodal (re)staging in breast cancer patients: results of a validation study.
van Nijnatten TJA; Schipper RJ; Lobbes MBI; van Roozendaal LM; Vöö S; Moossdorff M; Paiman ML; de Vries B; Keymeulen KBMI; Wildberger JE; Smidt ML; Beets-Tan RGH
Clin Radiol; 2018 Feb; 73(2):168-175. PubMed ID: 29029766
[TBL] [Abstract][Full Text] [Related]
7. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
[TBL] [Abstract][Full Text] [Related]
8. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
[TBL] [Abstract][Full Text] [Related]
9. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.
Memarsadeghi M; Riedl CC; Kaneider A; Galid A; Rudas M; Matzek W; Helbich TH
Radiology; 2006 Nov; 241(2):367-77. PubMed ID: 17057065
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging for axillary staging in patients with breast cancer.
Mortellaro VE; Marshall J; Singer L; Hochwald SN; Chang M; Copeland EM; Grobmyer SR
J Magn Reson Imaging; 2009 Aug; 30(2):309-12. PubMed ID: 19466713
[TBL] [Abstract][Full Text] [Related]
11. Application of MR mammography beyond local staging: is there a potential to accurately assess axillary lymph nodes? evaluation of an extended protocol in an initial prospective study.
Baltzer PA; Dietzel M; Burmeister HP; Zoubi R; Gajda M; Camara O; Kaiser WA
AJR Am J Roentgenol; 2011 May; 196(5):W641-7. PubMed ID: 21512057
[TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes.
Murray AD; Staff RT; Redpath TW; Gilbert FJ; Ah-See AK; Brookes JA; Miller ID; Payne S
Br J Radiol; 2002 Mar; 75(891):220-8. PubMed ID: 11932214
[TBL] [Abstract][Full Text] [Related]
13. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
14. Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy.
Javid S; Segara D; Lotfi P; Raza S; Golshan M
Ann Surg Oncol; 2010 Jul; 17(7):1841-6. PubMed ID: 20143266
[TBL] [Abstract][Full Text] [Related]
15. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
[TBL] [Abstract][Full Text] [Related]
16. Performance of gadofosveset-enhanced MRI for staging rectal cancer nodes: can the initial promising results be reproduced?
Heijnen LA; Lambregts DM; Martens MH; Maas M; Bakers FC; Cappendijk VC; Oliveira P; Lammering G; Riedl RG; Beets GL; Beets-Tan RG
Eur Radiol; 2014 Feb; 24(2):371-9. PubMed ID: 24051676
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted magnetic resonance imaging in the characterization of axillary lymph nodes in patients with breast cancer.
Fornasa F; Nesoti MV; Bovo C; Bonavina MG
J Magn Reson Imaging; 2012 Oct; 36(4):858-64. PubMed ID: 22648570
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Performance of Dedicated Axillary T2- and Diffusion-weighted MR Imaging for Nodal Staging in Breast Cancer.
Schipper RJ; Paiman ML; Beets-Tan RG; Nelemans PJ; de Vries B; Heuts EM; van de Vijver KK; Keymeulen KB; Brans B; Smidt ML; Lobbes MB
Radiology; 2015 May; 275(2):345-55. PubMed ID: 25513854
[TBL] [Abstract][Full Text] [Related]
19. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
20. Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients.
van Nijnatten TJA; Ploumen EH; Schipper RJ; Goorts B; Andriessen EH; Vanwetswinkel S; Schavemaker M; Nelemans P; de Vries B; Beets-Tan RGH; Smidt ML; Lobbes MBI
Eur J Radiol; 2016 Dec; 85(12):2288-2294. PubMed ID: 27842679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
